Myopia Control in European Children - Study Protocol and Methodology
| Authors | |
|---|---|
| Year of publication | 2022 |
| Type | Article in Periodical |
| Magazine / Source | HSOA Journal of Neonatology and Clinical Pediatrics |
| MU Faculty or unit | |
| Citation | |
| Web | MARS |
| Doi | http://dx.doi.org/10.24966/NCP-878X/100096 |
| Keywords | Atropine eye drops; Axial length of eye; Low dose atropine; Myopia in children; Progressive myopia |
| Description | Purpose To report study protocol and methodology of multicentre, Randomized, double-blind, placebo-controlled study of the efficacy and safety of low dose atropine eye drops (0.02%, 0.04%) in slowing the progression of short-sightedness (myopia) in children. M.A.R.S. (Myopia and Atropin ReStriction). Conclusion M.A.R.S. clinical trial will enrich the knowledge about myopia and its possible treatment in the early stages in European children. It will be beneficial for paediatric patients, practicing paediatricians and ophthalmologist. In the future it will be helpful not only from a medical point of view, but also in economic aspect of management of progression of myopia in children and all the entire population. |
| Related projects: |